News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
36,857 Results
Type
Article (1356)
Company Profile (18)
Press Release (35354)
Section
Business (16841)
Career Advice (37)
Deals (2246)
Drug Delivery (3)
Drug Development (4575)
Employer Resources (10)
FDA (744)
Job Trends (988)
News (22176)
Policy (1049)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (87)
Accelerated approval (8)
ADA (1)
Allergies (10)
Alliances (1080)
ALS (3)
Alzheimer's disease (76)
Antibody-drug conjugate (ADC) (64)
Approvals (847)
Artificial intelligence (45)
ASCO (36)
Autoimmune disease (28)
Automation (1)
Bankruptcy (11)
Best Places to Work (975)
Biologics (1)
Biosimilars (9)
BioSpace Insights (4)
Biotechnology (5)
Bladder cancer (32)
Brain cancer (5)
Breast cancer (129)
Cancer (725)
Cardiovascular disease (49)
Career advice (35)
Career pathing (1)
CAR-T (23)
CDMO (7)
Cell therapy (65)
Cervical cancer (8)
Clinical research (4804)
Collaboration (104)
Commercialization (1)
Compensation (57)
Complete response letters (4)
COVID-19 (113)
CRISPR (7)
C-suite (33)
Cystic fibrosis (10)
Data (1037)
Denatured (1)
Depression (7)
Dermatology (11)
Diabetes (43)
Diagnostics (434)
Digital health (8)
Diversity, equity & inclusion (1)
Drug discovery (11)
Drug pricing (4)
Duchenne muscular dystrophy (20)
Earnings (16508)
Editorial (1)
Employer branding (3)
Employer resources (8)
Events (3257)
Executive appointments (39)
FDA (1180)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (81)
Gene editing (12)
Generative AI (3)
Gene therapy (53)
GLP-1 (89)
Government (137)
Guidances (174)
Healthcare (1119)
Hematology (15)
HIV (21)
Huntington's disease (2)
IgA nephropathy (12)
Immunology and inflammation (26)
Immuno-oncology (8)
Indications (30)
Infectious disease (134)
Inflammatory bowel disease (19)
Influenza (7)
Intellectual property (17)
Interviews (2)
IPO (1793)
IRA (3)
Job creations (87)
Job search strategy (32)
JPM (1)
Kidney cancer (6)
Labor market (15)
Layoffs (35)
Leadership (2)
Legal (128)
Liver cancer (8)
Lung cancer (130)
Lymphoma (88)
Machine learning (3)
Management (3)
Manufacturing (42)
MASH (28)
Medical device (901)
Medtech (924)
Mergers & acquisitions (523)
Metabolic disorders (125)
mRNA (11)
Multiple sclerosis (34)
NASH (5)
Neurodegenerative disease (21)
Neuropsychiatric disorders (11)
Neuroscience (198)
NextGen: Class of 2026 (240)
Non-profit (165)
Now hiring (1)
Obesity (50)
Opinion (6)
Ovarian cancer (16)
Pain (15)
Pancreatic cancer (29)
Parkinson's disease (15)
Partnered (3)
Patents (23)
Patient recruitment (31)
Peanut (2)
People (877)
Pharmaceutical (6)
Pharmacy benefit managers (5)
Phase 1 (988)
Phase 2 (1963)
Phase 3 (2187)
Pipeline (1799)
Policy (10)
Postmarket research (196)
Preclinical (219)
Press Release (8)
Prostate cancer (33)
Psychedelics (3)
Radiopharmaceuticals (25)
Rare diseases (94)
Real estate (95)
Recruiting (3)
Regulatory (1157)
Reports (9)
Research institute (83)
Resumes & cover letters (3)
Rett syndrome (5)
RSV (7)
Schizophrenia (28)
Series A (14)
Series B (6)
Sickle cell disease (12)
Special edition (4)
Spinal muscular atrophy (8)
Startups (93)
Stomach cancer (2)
Supply chain (1)
Tariffs (2)
The Weekly (1)
Vaccines (78)
Venture capital (6)
Weight loss (30)
Women's health (8)
Worklife (1)
Date
Today (3)
Last 7 days (45)
Last 30 days (133)
Last 365 days (2728)
2026 (1895)
2025 (2752)
2024 (2822)
2023 (2785)
2022 (3272)
2021 (3415)
2020 (2978)
2019 (2492)
2018 (1892)
2017 (1485)
2016 (1100)
2015 (1573)
2014 (1055)
2013 (643)
2012 (830)
2011 (945)
2010 (853)
Location
Africa (37)
Alabama (4)
Arizona (21)
Asia (3101)
Australia (242)
California (1170)
Canada (328)
China (125)
Colorado (59)
Connecticut (77)
Delaware (59)
Europe (5663)
Florida (176)
Georgia (43)
Hawaii (1)
Idaho (1)
Illinois (132)
India (5)
Indiana (75)
Iowa (3)
Japan (82)
Kansas (5)
Kentucky (6)
Louisiana (14)
Maine (11)
Maryland (175)
Massachusetts (800)
Michigan (31)
Minnesota (74)
Mississippi (1)
Missouri (12)
Montana (3)
Nebraska (1)
Nevada (5)
New Hampshire (11)
New Jersey (560)
New Mexico (1)
New York (319)
North Carolina (201)
Northern California (652)
Ohio (32)
Oklahoma (1)
Oregon (1)
Pennsylvania (303)
Rhode Island (3)
South America (59)
South Carolina (2)
Southern California (424)
Tennessee (19)
Texas (175)
United States (4593)
Utah (49)
Virginia (28)
Washington D.C. (4)
Washington State (101)
Wisconsin (15)
36,857 Results for "54".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Waterfall Scientific Awarded Up to $54.5 Million from ARPA-H to Lead Consortium Developing Continuous-Flow Cell-Free mRNA Manufacturing and Characterization Platform
September 2, 2026
·
4 min read
Press Releases
Qolab Announces $54.2 Million Series B Financing and Commitments Led by UC Investments to Accelerate the Future of Quantum Computing
July 2, 2026
·
3 min read
Press Releases
Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
August 5, 2026
·
5 min read
Press Releases
Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development
April 10, 2026
·
4 min read
Press Releases
Abbott increases quarterly dividend for 54th consecutive year
December 15, 2025
·
1 min read
Press Releases
Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54
March 30, 2026
·
8 min read
influenza
Moderna Scores $54 Million From CEPI To Fund Bird Flu Vaccine
The money replaces a small portion of a contract Moderna lost when the Department of Health and Human Services canceled $760 million in backing to develop the vaccine, called mRNA-1018.
December 18, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
BD Board Increases Dividend for 54th Consecutive Year
November 6, 2025
·
2 min read
Press Releases
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting
March 30, 2026
·
10 min read
Press Releases
Cell and Gene Therapy Clinical Trials Market Size Expected to Hit USD 54.29 Bn by 2034
August 7, 2025
·
1 min read
1 of 3,686
Next
